Groh, Matthieu http://orcid.org/0000-0003-0810-136X
Rohmer, Julien
Etienne, Nicolas
Abou Chahla, Wadih
Baudet, Antoine
Chan Hew Wai, Aurélie
Chenivesse, Cécile
Clisson Rusek, Irena
Cottin, Vincent
Decamp, Matthieu
De Groote, Pascal
Delahousse, Fanny
Duployez, Nicolas
Faguer, Stanislas
Gottrand, Frédéric
Huang, Florent
Leblanc, Thierry
Magnan, Antoine
Martin, Thierry
Mortuaire, Geoffrey
Néel, Antoine
Paris, Luc
Petit, Arnaud
Rossignol, Julien
Schleinitz, Nicolas
Soret-Dulphy, Juliette
Staumont-Salle, Delphine
Terrier, Benjamin
Terriou, Louis
Viallard, Jean-François
Lefèvre, Guillaume
Kahn, Jean-Emmanuel
Article History
Received: 18 January 2023
Accepted: 2 April 2023
First Online: 30 April 2023
Declarations
:
: Not applicable.
: Not applicable.
: MG reports consulting fees from GlaxoSmithKline and AstraZeneca; speaking fees from GlaxoSmithKline, AstraZeneca and Sanofi; JRoh reports consulting fees from GlaxoSmithKline; speaking fees from GlaxoSmithKline; VC reports consulting fees from CSL Behring and AstraZeneca; speaking fees from AstraZeneca; ND reports consulting fees from Bristol Myers Squibb; SF reports consulting fees from Abyonix Pharma, Novartis, GlaxoSmithKline, Sanofi-Genzyme, CSL Vifor, Alexion; speeking fees from Baxter, Sanofi-Genzyme, CSL-Vifor; FG reports consulting fees from Nestlé; MH reports consulting fees from GlaxoSmithKline and Blueprint; speaking fees from Novartis, GlaxoSmithKline and Sanofi. AM reports consulting fees form GlaxoSmithKline, AstraZeneca and Novartis; speeking fees from GlaxoSmithKline, AstraZeneca and Novartis; TM reports consulting fees from Amgen, Chugai, Boehringer; speaking fees from GlaxoSmithKline; JRos reports speeking fees from Novartis; JSD reports consulting fees from Novartis; DSS reports grants from AstraZeneca and Sanofi-Genzyme; consulting fees from Astra-Zeneca, Novartis, Sanofi; speeking fees from Novartis and Sanofi-Genzyme; JFV reports consulting fees from GlaxoSmithKline; GL reports consulting fees from GlaxoSmithKline and AstraZeneca; speaking fees from GlaxoSmithKline and AstraZeneca. JEK reports consulting fees from GlaxoSmithKline and AstraZeneca.